Component
Whole-blood manganese concentration
Whole-blood manganese concentration. Experimental scope belongs to each linked claim.
3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
After more frequent chelation and added ferrous fumarate, blood manganese, MRI and liver findings improved; later iron dosing was reduced after serum iron rose excessively.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- Ferrous fumarate (added_treatment); Calcium disodium edetate (concurrent_treatment); Iron (interacting_nutrient); Manganese (affected_nutrient)
- evidence_span
- {"source_cache": "artifacts/manganese-clinical-sources/stamelou2012.txt", "locator": "Clinical description; age 15–16 treatment changes", "file_sha256": "5d86a26fe564508fb382d1c8df61f531bfbaf06b69e2078b0999e3a3129555f6", "start_char": 9842, "end_char": 10521, "text_sha256": "2da91cbaa297984ac1c90caf8701ce0a3f9a633b806ef4fff178b6ecc46c8aa1", "text_characters": 679}
- experimental_model
- Ten-year longitudinal report of one SLC30A10 patient
- exposure
- Calcium disodium edetate chelation; subsequent increase in chelation frequency and addition of oral ferrous fumarate.
- limitations
- Repeated observations in one previously described patient. Combined treatment changes prevent attribution of later benefit to iron alone; disease-specific treatment is not routine nutrient replacement.
- nutrient_topic
- Manganese research collection; topical membership is not evidence of a direct dietary effect. · Manganese
- organism
- Homo sapiens
- plain_language
- The combined regimen affected both manganese removal and iron status.
- primary_references
- [mn-clin-stamelou2012] Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. (2012). https://pubmed.ncbi.nlm.nih.gov/22926781/ DOI: 10.1002/mds.25138
- tissue_or_cell_type
- Urine, blood, brain MRI and motor function
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Manganese: enzyme cofactors, glycosylation, transport and nutrient interactions (2026-09-17) · lines 1314–1326
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ten-year longitudinal report of one SLC30A10 patient · source_derived_draft · unverified_draft
### mn-clin-iron-chelation-combination After more frequent chelation and added ferrous fumarate, blood manganese, MRI and liver findings improved; later iron dosing was reduced after serum iron rose excessively. Condition category: machinery_impairment nutrient_topic: Manganese research collection; topical membership is not evidence of a direct dietary effect. plain_language: The combined regimen affected both manganese removal and iron status. organism: Homo sapiens tissue_or_cell_type: Urine, blood, brain MRI and motor function experimental_model: Ten-year longitudinal report of one SLC30A10 patient limitations: Repeated observations in one previously described patient. Combined treatment changes prevent attribution of later benefit to iron alone; disease-specific treatment is not routine nutrient replacement. exposure: Calcium disodium edetate chelation; subsequent increase in chelation frequency and addition of oral ferrous fumarate. cross_nutrient: Ferrous fumarate (added_treatment); Calcium disodium edetate (concurrent_treatment); Iron (interacting_nutrient); Manganese (affected_nutrient) evidence_span: {"source_cache": "artifacts/manganese-clinical-sources/stamelou2012.txt", "locator": "Clinical description; age 15–16 treatment changes", "file_sha256": "5d86a26fe564508fb382d1c8df61f531bfbaf06b69e2078b0999e3a3129555f6", "start_char": 9842, "end_char": 10521, "text_sha256": "2da91cbaa297984ac1c90caf8701ce0a3f9a633b806ef4fff178b6ecc46c8aa1", "text_characters": 679} [mn-clin-stamelou2012] Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. (2012). https://pubmed.ncbi.nlm.nih.gov/22926781/ DOI: 10.1002/mds.25138
Complete structured claim and evidence
Where it participates (unsigned role)
Chelation increased urinary manganese and reduced blood manganese in the followed SLC30A10 patient.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- Whole-blood manganese concentration (reduced_endpoint); Manganese (removed_nutrient)
- evidence_span
- {"source_cache": "artifacts/manganese-clinical-sources/stamelou2012.txt", "locator": "Clinical description; initial calcium disodium edetate treatment", "file_sha256": "5d86a26fe564508fb382d1c8df61f531bfbaf06b69e2078b0999e3a3129555f6", "start_char": 8926, "end_char": 9841, "text_sha256": "0bc6daa528aab341fb9d91dc543811ba24f7f8e904f084c085bafc1d4093113e", "text_characters": 915}
- experimental_model
- Ten-year longitudinal report of one SLC30A10 patient
- exposure
- Calcium disodium edetate chelation; subsequent increase in chelation frequency and addition of oral ferrous fumarate.
- limitations
- Repeated observations in one previously described patient. Combined treatment changes prevent attribution of later benefit to iron alone; disease-specific treatment is not routine nutrient replacement.
- nutrient_topic
- Manganese research collection; topical membership is not evidence of a direct dietary effect. · Manganese
- organism
- Homo sapiens
- plain_language
- The treatment moved more manganese into urine.
- primary_references
- [mn-clin-stamelou2012] Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. (2012). https://pubmed.ncbi.nlm.nih.gov/22926781/ DOI: 10.1002/mds.25138
- tissue_or_cell_type
- Urine, blood, brain MRI and motor function
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Manganese: enzyme cofactors, glycosylation, transport and nutrient interactions (2026-09-17) · lines 1272–1284
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ten-year longitudinal report of one SLC30A10 patient · source_derived_draft · unverified_draft
### mn-clin-chelation-manganese-removal Chelation increased urinary manganese and reduced blood manganese in the followed SLC30A10 patient. Condition category: machinery_impairment nutrient_topic: Manganese research collection; topical membership is not evidence of a direct dietary effect. plain_language: The treatment moved more manganese into urine. organism: Homo sapiens tissue_or_cell_type: Urine, blood, brain MRI and motor function experimental_model: Ten-year longitudinal report of one SLC30A10 patient limitations: Repeated observations in one previously described patient. Combined treatment changes prevent attribution of later benefit to iron alone; disease-specific treatment is not routine nutrient replacement. exposure: Calcium disodium edetate chelation; subsequent increase in chelation frequency and addition of oral ferrous fumarate. cross_nutrient: Whole-blood manganese concentration (reduced_endpoint); Manganese (removed_nutrient) evidence_span: {"source_cache": "artifacts/manganese-clinical-sources/stamelou2012.txt", "locator": "Clinical description; initial calcium disodium edetate treatment", "file_sha256": "5d86a26fe564508fb382d1c8df61f531bfbaf06b69e2078b0999e3a3129555f6", "start_char": 8926, "end_char": 9841, "text_sha256": "0bc6daa528aab341fb9d91dc543811ba24f7f8e904f084c085bafc1d4093113e", "text_characters": 915} [mn-clin-stamelou2012] Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. (2012). https://pubmed.ncbi.nlm.nih.gov/22926781/ DOI: 10.1002/mds.25138
Complete structured claim and evidenceWhole-blood manganese and pallidal T1-weighted MRI signal changed with manganese administration and withdrawal; their correlation was r=0.7693.
Experimental context and source evidence
- cross_nutrient
- Whole-blood manganese concentration (correlated_marker); Manganese (administered_nutrient)
- evidence_span
- {"source_cache": "artifacts/manganese-clinical-sources/takagi2001.abstract.txt", "locator": "Indexed primary abstract", "file_sha256": "e5336a20271762ff7375cfe777c71c9b721c68bc47ae09e9a36b8eaac2953b8c", "start_char": 0, "end_char": 1726, "text_sha256": "e5336a20271762ff7375cfe777c71c9b721c68bc47ae09e9a36b8eaac2953b8c", "text_characters": 1726}
- experimental_model
- On-off manganese study in 11 adults on home parenteral nutrition
- exposure
- Parenteral nutrition containing 0 or 20 micromoles Mn/day; serial blood and MRI measurements.
- limitations
- Intravenous exposure bypasses intestinal regulation. T1-weighted signal is a deposition-related marker, not by itself proof of neurological disability or a general dietary threshold.
- nutrient_topic
- Manganese research collection; topical membership is not evidence of a direct dietary effect. · Manganese
- organism
- Homo sapiens
- plain_language
- Blood and brain imaging responded together under this intravenous exposure.
- primary_references
- [mn-clin-takagi2001] On-off study of manganese administration to adult patients undergoing home parenteral nutrition: new indices of in vivo manganese level. (2001). https://pubmed.ncbi.nlm.nih.gov/11284475/ DOI: 10.1177/014860710102500287
- tissue_or_cell_type
- Whole blood and brain MRI
Manganese: enzyme cofactors, glycosylation, transport and nutrient interactions (2026-09-17) · lines 1328–1340
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · On-off manganese study in 11 adults on home parenteral nutrition · source_derived_draft · unverified_draft
### mn-clin-parenteral-marker-response Whole-blood manganese and pallidal T1-weighted MRI signal changed with manganese administration and withdrawal; their correlation was r=0.7693. Condition category: normal nutrient_topic: Manganese research collection; topical membership is not evidence of a direct dietary effect. plain_language: Blood and brain imaging responded together under this intravenous exposure. organism: Homo sapiens tissue_or_cell_type: Whole blood and brain MRI experimental_model: On-off manganese study in 11 adults on home parenteral nutrition limitations: Intravenous exposure bypasses intestinal regulation. T1-weighted signal is a deposition-related marker, not by itself proof of neurological disability or a general dietary threshold. exposure: Parenteral nutrition containing 0 or 20 micromoles Mn/day; serial blood and MRI measurements. cross_nutrient: Whole-blood manganese concentration (correlated_marker); Manganese (administered_nutrient) evidence_span: {"source_cache": "artifacts/manganese-clinical-sources/takagi2001.abstract.txt", "locator": "Indexed primary abstract", "file_sha256": "e5336a20271762ff7375cfe777c71c9b721c68bc47ae09e9a36b8eaac2953b8c", "start_char": 0, "end_char": 1726, "text_sha256": "e5336a20271762ff7375cfe777c71c9b721c68bc47ae09e9a36b8eaac2953b8c", "text_characters": 1726} [mn-clin-takagi2001] On-off study of manganese administration to adult patients undergoing home parenteral nutrition: new indices of in vivo manganese level. (2001). https://pubmed.ncbi.nlm.nih.gov/11284475/ DOI: 10.1177/014860710102500287
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.